X4 Pharmaceuticals (XFOR) Payables (2018 - 2025)
Historic Payables for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $5.1 million.
- X4 Pharmaceuticals' Payables fell 4108.66% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 4108.66%. This contributed to the annual value of $8.6 million for FY2024, which is 364.37% down from last year.
- X4 Pharmaceuticals' Payables amounted to $5.1 million in Q3 2025, which was down 4108.66% from $7.7 million recorded in Q2 2025.
- X4 Pharmaceuticals' Payables' 5-year high stood at $11.1 million during Q1 2025, with a 5-year trough of $2.4 million in Q3 2021.
- Moreover, its 5-year median value for Payables was $6.0 million (2023), whereas its average is $6.2 million.
- As far as peak fluctuations go, X4 Pharmaceuticals' Payables skyrocketed by 14767.63% in 2021, and later crashed by 4108.66% in 2025.
- Quarter analysis of 5 years shows X4 Pharmaceuticals' Payables stood at $4.3 million in 2021, then skyrocketed by 81.58% to $7.8 million in 2022, then rose by 15.04% to $8.9 million in 2023, then decreased by 3.64% to $8.6 million in 2024, then crashed by 41.39% to $5.1 million in 2025.
- Its Payables stands at $5.1 million for Q3 2025, versus $7.7 million for Q2 2025 and $11.1 million for Q1 2025.